-
Viable Rate of Return for Social Impact Bonds Supporting Research and Development of Gene Therapies for Rare Conditions
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Rozanolixizumab for the Treatment of Generalized Myasthenia Gravis (gMG) in Greece
Sep 9, 2025, 16:22 PM -
Impact of Nontransfusion-Dependent Thalassemia on Adult Patients' Health-Related Quality of Life and Work Productivity in the Kingdom of Saudi Arabia and United Arab Emirates
Sep 9, 2025, 16:22 PM -
Real Option Value of Sotatercept in Pulmonary Arterial Hypertension: A Health Economic Perspective on Future Treatment Opportunities
Sep 9, 2025, 16:22 PM -
A Cost per Responder Analysis of Lipid-Lowering Therapies in Patients With Established Atherosclerotic Cardiovascular Disease in Italy
Sep 9, 2025, 16:22 PM -
Leveling the Field: How the MFN Could Transform Drug Pricing
Sep 9, 2025, 16:22 PM -
Impact of the Severity of Disease-Related Malnutrition on Healthcare Resource Utilization in Pediatric Patients 1 Year and Older
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Direct Oral Anticoagulants vs. Vitamin K Antagonists in Algeria: A Public Payer Perspective
Sep 9, 2025, 16:22 PM -
The SISAQOL-IMI Recommendations on Standardizing the Use of Thresholds for Interpretation of Patient-Reported Outcome Results in Cancer Clinical Trials
Sep 9, 2025, 16:22 PM -
Scoping the Future: Using NICE Scopes to Inform PICO Prediction for EU Joint Clinical Assessment
Sep 9, 2025, 16:22 PM -
Accelerating Therapeutic Innovation: Early Results From France’s Accès Direct Scheme
Sep 9, 2025, 16:22 PM -
Current Treatment Pathway for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in England: Insights From a Qualitative Validation With Clinical Experts
Sep 9, 2025, 16:22 PM -
Systems-Level Modeling Approaches for Complex Health Technologies: A Systematic Review
Sep 9, 2025, 16:22 PM -
Epidemiology Treatment Patterns and Outcomes in Gestational Trophoblastic Neoplasia: A Systematic Literature Review and Gap Analysis
Sep 9, 2025, 16:22 PM -
Trends of Prescriptions for Medical Technologies Not Covered by the Colombian Health Benefits Package Between 2020 and 2024: A Descriptive Study
Sep 9, 2025, 16:22 PM -
Socioeconomic and Geographic Inequalities in Colorectal Cancer Care Utilization and Expenditures: A Decomposition Analysis
Sep 9, 2025, 16:22 PM -
Budget Impact of Implementing a Case-Finding Program in UK Patients at High Risk for COPD to Explore Cost Savings Due to Earlier Diagnosis
Sep 9, 2025, 16:22 PM -
Level of ICER of Health Economic Assessment in France in 2024
Sep 9, 2025, 16:22 PM -
The Enduring Economic Burden of COVID-19 and the Value of Vaccination Strategies in High-Income Countries
Sep 9, 2025, 16:22 PM -
Real-World Pharmacovigilance of Metoprolol: A Disproportionality Analysis of Adverse Events Using US FDA Adverse Event Reporting System (FAERS) and Bioinformatics
Sep 9, 2025, 16:22 PM
